ACOSENSE AB

Their core work

ACOSENSE AB is a Swedish deep-tech SME that developed the world's first acoustic chemometer — an instrument that uses sound waves to analyze the composition of fluids in real time, without chemical reagents or sampling. Their core technology, branded ACOSENSE, enables continuous online monitoring of industrial fluid streams, measuring properties such as concentration, viscosity, and composition acoustically. The company progressed from feasibility research to a market-ready instrument through the EU SME Instrument program, indicating they have moved from R&D into commercialization. Their target customers are process industries where fluid quality monitoring is critical — chemical plants, food and beverage production, water treatment, and oil and gas.

What they specialise in

How they've shifted over time

ACOSENSE AB has a short but coherent trajectory: they entered H2020 funding in 2018 with a feasibility study (ACOSPECTOR, SME Phase 1) to validate the acoustic chemometer concept, then immediately progressed in 2019 to a full-scale development project (ACOSENSE, SME Phase 2) to build the commercial instrument. There is no keyword divergence because both projects are part of a single technology development arc — from proof-of-concept to product. The shift is not in domain but in maturity: from "can this work?" to "build and commercialize it."

ACOSENSE AB is on a clear commercialization trajectory — having completed the EU-funded development phase by 2022, they are likely now focused on market entry and scaling the ACOSENSE instrument to industrial customers.

How they like to work

ACOSENSE AB has acted exclusively as project coordinator in both H2020 projects, which under the SME Instrument program is standard — SME Phase 1 and Phase 2 are single-beneficiary grants, not consortium projects. As a result, they show zero registered consortium partners and no cross-country collaboration in the H2020 record. This does not mean they are isolated; rather, their EU funding strategy was designed for fast, focused technology development without consortium overhead. Any future collaboration with them would likely position them as a technology provider or pilot-site partner, not as a consortium manager.

ACOSENSE AB's H2020 participation is entirely through single-beneficiary SME Instrument grants, so no consortium partners are recorded in EU project data. Their real collaboration network — with industrial pilot customers, distributors, and research validators — would need to be assessed through company-level sources rather than CORDIS.

What sets them apart

ACOSENSE AB occupies a rare niche: acoustic chemometry for real-time fluid analysis is a technology with very few direct competitors globally, and claiming to build the "first" such instrument gives them a potential first-mover position. For consortium builders, they offer a validated, EU-funded deep-tech sensor technology that is ready (or nearly ready) for industrial pilots — particularly valuable in any project requiring non-invasive, continuous monitoring of liquids. Their Gothenburg base also places them in the heart of Sweden's industrial and maritime cluster, giving practical access to process industry test environments.

Highlights from their portfolio

• ACOSENSE
  The flagship project with EUR 1.37M in EC funding under SME Phase 2 — the full commercial development of the acoustic online instrument, making it the largest and most consequential project in the company's portfolio.
• ACOSPECTOR
  The SME Phase 1 feasibility study that validated the acoustic chemometer concept and unlocked the Phase 2 grant, demonstrating a disciplined technology development pathway.